Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nitesh D Kuhadiya

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Clinical Case Reports|May 3, 2021
Effects of concomitant combination of SGLT-2 inhibitor and GLP-1 receptor agonist on renal outcomes in T2D with eGFR below 30 and macroalbuminuria: A case seriesNitesh D Kuhadiya, Israa Mahmood
AACE Clinical Case Reports|March 15, 2021
Pembrolizumab-Associated Hypoparathyroidism: A Single Case ReportIsraa Mahmood, Nitesh D Kuhadiya, Michael Gonzalaes
Diabetes Care|January 26, 2012
Comment on: Wehr et al. Low free testosterone levels are associated with all-cause and cardiovascular mortality in postmenopausal diabetic women. Diabetes Care 2011;34:1771-1777Nitesh D Kuhadiya, Sandeep Dhindsa, Paresh Dandona
Journal of the American Geriatrics Society|February 14, 2014
Sleep-related painful erections in an elderly man successfully treated using clonazepamNitesh D Kuhadiya, Akshata Desai, Michelle Reisner
Diabetes, Obesity & Metabolism|December 12, 2018
Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetesNitesh D Kuhadiya, Ben Prohaska, Husam Ghanim, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 6, 2016
ADJUNCT THERAPIES IN TYPE 1 DIABETESParesh Dandona, Nitesh D Kuhadiya, Husam Ghanim, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 15, 2018
VISUAL VIGNETTESartaj S Sandhu, Sandeep S Dhindsa, Nitesh D Kuhadiya, et al.
Diabetes, Obesity & Metabolism|November 29, 2016
Exenatide induces an increase in vasodilatory and a decrease in vasoconstrictive mediatorsAjay Chaudhuri, Husam Ghanim, Antoine Makdissi, et al.
The Journal of Clinical Endocrinology and Metabolism|December 2, 2016
Antiinflammatory and ROS Suppressive Effects of the Addition of Fiber to a High-Fat High-Calorie MealHusam Ghanim, Manav Batra, Sanaa Abuaysheh, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 29, 2013
Liraglutide as additional treatment to insulin in obese patients with type 1 diabetes mellitusNitesh D Kuhadiya, Ritu Malik, Natalie J Bellini, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Clinical Case Reports|May 3, 2021
Effects of concomitant combination of SGLT-2 inhibitor and GLP-1 receptor agonist on renal outcomes in T2D with eGFR below 30 and macroalbuminuria: A case seriesNitesh D Kuhadiya, Israa Mahmood
AACE Clinical Case Reports|March 15, 2021
Pembrolizumab-Associated Hypoparathyroidism: A Single Case ReportIsraa Mahmood, Nitesh D Kuhadiya, Michael Gonzalaes
Diabetes Care|January 26, 2012
Comment on: Wehr et al. Low free testosterone levels are associated with all-cause and cardiovascular mortality in postmenopausal diabetic women. Diabetes Care 2011;34:1771-1777Nitesh D Kuhadiya, Sandeep Dhindsa, Paresh Dandona
Journal of the American Geriatrics Society|February 14, 2014
Sleep-related painful erections in an elderly man successfully treated using clonazepamNitesh D Kuhadiya, Akshata Desai, Michelle Reisner
Diabetes, Obesity & Metabolism|December 12, 2018
Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetesNitesh D Kuhadiya, Ben Prohaska, Husam Ghanim, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 6, 2016
ADJUNCT THERAPIES IN TYPE 1 DIABETESParesh Dandona, Nitesh D Kuhadiya, Husam Ghanim, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 15, 2018
VISUAL VIGNETTESartaj S Sandhu, Sandeep S Dhindsa, Nitesh D Kuhadiya, et al.
Diabetes, Obesity & Metabolism|November 29, 2016
Exenatide induces an increase in vasodilatory and a decrease in vasoconstrictive mediatorsAjay Chaudhuri, Husam Ghanim, Antoine Makdissi, et al.
The Journal of Clinical Endocrinology and Metabolism|December 2, 2016
Antiinflammatory and ROS Suppressive Effects of the Addition of Fiber to a High-Fat High-Calorie MealHusam Ghanim, Manav Batra, Sanaa Abuaysheh, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 29, 2013
Liraglutide as additional treatment to insulin in obese patients with type 1 diabetes mellitusNitesh D Kuhadiya, Ritu Malik, Natalie J Bellini, et al.
Pageof 3